Navigation Links
Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease

that increased AtherOx levels were found in coronary patients with more severe disease as judged by cardiac catheterization, and correlated with adverse outcomes or complications such as new angioplasty, stent replacement, failure of coronary artery bypass grafts, heart attacks, strokes and even cardiovascular death. Luis Lopez, MD, Corgenix' Chief Medical Officer said "Interestingly, data from this study suggests the combined presence of both AtherOx complexes and anti-phospholipid antibodies could infer an increased risk for vascular complications in coronary artery disease patients."

Douglass Simpson, Corgenix' President and Chief Executive Officer said, "We are pleased to see this exciting new data on the AtherOx technology. We believe this unique science targets a significant worldwide clinical need, and we look forward to seeing additional data over the next year, leading to the opportunity to bring these products to the market. As new clinical findings continue to validate the utility of AtherOx and anti-AtherOx, we anticipate this technology has the potential to become an important addition to medical care worldwide."

"These findings indicate important relationships between AtherOx and the severity of cardiovascular disease," added Dr. Lopez. "We hope to have the ability to match patients with a treatment that may improve their survival, and if borne out in the ongoing clinical studies now undergoing analysis, could fulfill the promise of reducing the incidence of cardiovascular disease."

About AtherOx(TM)

The AtherOx technology utilizes oxidized low-density-lipoprotein (oxLDL) complexed with the plasma protein B2GPI. Although oxLDL has been implicated in cardiovascular disease, clinical data demonstrates that the determination of AtherOx, rather than oxLDL alone, is more predictive of the risk of progressive atherosclerotic cardiovascular disease. Corgenix licensed this technology in 2002, and is developing several products util
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
2. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
3. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
4. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
7. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
8. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
9. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
10. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
11. Bentley Reports Positive Results with Nasulin Intranasal Insulin Spray at the American Diabetes Association Meeting
Post Your Comments:
(Date:12/22/2014)... NxStage Medical, Inc. (NASDAQ: NXTM ... announced today that the U.S. Food and Drug ... perform hemodialysis overnight while the patient is at ... System One is the first and only hemodialysis ... Home nocturnal hemodialysis is an ...
(Date:12/22/2014)... 22, 2014 Research and Markets ... the "Investment Analysis of the US Medical ... http://photos.prnewswire.com/prnh/20130307/600769 ... medical device sector identifies the key trends and ... investments, and mergers and acquisitions. The ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals ... company focused on discovering, developing and commercializing innovative ... technologies, today issued the following open letter to ... , Dr. Med. Sc. Dear RXi ... a number of inaccurate statements posted on certain ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3Investment Analysis of the US Medical Device Sector 2RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6
... Dec. 3, 2010 Streamline Health Solutions, Inc. (Nasdaq: ... quarter fiscal year 2010 financial results for the period ended ... market closes. The Company will conduct a conference call and ... 2010 at 4:30 p.m. ET. Interested parties can ...
... 3, 2010 InfraReDx, Inc. , a medical ... announced that James E. Muller, M.D., founder and chief ... Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference, to be ... San Francisco. The InfraReDx presentation is ...
Cached Medicine Technology:Streamline Health to Announce Third Quarter Fiscal Year 2010 Financial Results on Wednesday, December 8 2
(Date:12/26/2014)... December 26, 2014 Pentec Health, Inc. ... the state of Pennsylvania for 2014. The awards program, ... programs of its kind in the country. The program ... Pennsylvania Department of Community and Economic Development, the Pennsylvania ... and the Central Penn Business Journal. , ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... 25, 2014 Product liability lawsuits filed ... recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in ... Order issued in the U.S. District Court, Northern District ... an open conference on January 7, 2015, at the ... in West Palm Beach, Florida. The Conference is scheduled ...
(Date:12/25/2014)... December 25, 2014 The short film “Color ... created in honor of a true 9/11 hero, Welles Remy ... festivals including the 24 hours of Nuremberg International Short Film ... , Actress, screenwriter and director Luciana Lagana ... film together with her husband, Gregory Graham - ...
(Date:12/25/2014)... When head lice hits a home or school, parents and ... of it while keeping it from taking over the house ... solution right in their neighborhood: Lice Troopers . Expanding ... spectrum head lice screening and treatment services to families and ... Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , The ...
Breaking Medicine News(10 mins):Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... May 1, 2009, 7 am to 5 pm, ... of Michigan,s key stakeholders in disability benefits and workers, ... , is a group of volunteers from a ... promoting safer, healthier working lifestyles and preserving the employability ...
... TeamHealth Teleradiology has earned its second consecutive ... the company announced today."Organizations awarded this Gold Seal ... ensures innovative solutions are used for the most ... executive director of The Joint Commission,s Ambulatory Care ...
... elastography allows physicians to give a more accurate ... performed at Singapore General Hospital in Singapore. Breast ... the mechanical properties of tissues (relative stiffness) as ... backscatter of transmitted ultrasound waves through tissues. ...
... drainage of tubo ovarian abscesses help women avoid surgery, ... in Boston, MA. Tubo ovarian abscesses (TOAs) are an ... or ovaries. They can occur in patients with complicated ... , The study included 54 TOAs in 46 patients. ...
... as smoking and the direct impact on a senior,s health ... April 29 - May 3 in Chicago, IL. The ... past smokers and had never smoked. All three groups ... speed at which participants walked. After five years, it ...
... The following statement may be attributed to Jennifer ... from a veterinarian, Franck,s Pharmacy prepared medication that was ... Polo team. As soon as we learned of the ... led by an outside lawyer and, upon its conclusion, ...
Cached Medicine News:Health News:Workability in Michigan Summit to be Held May 1 2Health News:Joint Commission Awards TeamHealth Teleradiology Second Consecutive Gold Seal of Approval(TM) 2Health News:How late is too late to break bad habits? 2
... Anatomically Correct Design Is Unique Among All Lid ... Support The Lids Through An Anatomically Correct Arc ... With All Other Lid Speculums Which Pull Straight ... Tarsal Plate As They Open. Gentle Support ...
... Footplates Are Turned 90 Degrees To ... Blade While Incising Tissue. ,Special Mirror-Polished Double ... Penetration.,Pre-Set Blade Extension Settings Of 0.5mm, ... Full Extension.,1mm Wide Snub Nose Diamond ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
Pocket-sized instrument with 2.5X magnification....
Medicine Products: